Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: A retrospective, exploratory analysis in EMILIA - Krop, I E; Lin, N U; Blackwell, K; Guardino, E; Huober, J; Lu, M (Ann Oncol, 2015)
et al.